NEU 2.81% $18.65 neuren pharmaceuticals limited

Ann: 2023 Annual Report to shareholders, page-154

  1. 6,080 Posts.
    lightbulb Created with Sketch. 1613
    After reading all this $$$$$$$$$$$$$'s and models talk for longer than I care to contemplate, I'll give my prediction.

    If all goes well with the next two P2's (not a given yet) there will be TO accepted at around $50 before year's end.

    Why? Because if I am correct, that will do me. If I am rong to the upside, then it will be a very pleasant surprise. If I am rong to the downside, then the P2 results will not be as expected (and in many cases assumed) and the risk I undertook will be in vain - tough titties, but that is gambling.
 
watchlist Created with Sketch. Add NEU (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.